By Josh White
Date: Monday 01 Dec 2025
(Sharecast News) - Ixico strengthened its scientific advisory board on Monday, with the appointment of two leading global authorities in Alzheimer's and cerebrovascular disease, bolstering its strategy to expand biomarker innovation in dementia research.
By Josh White
Date: Monday 17 Nov 2025
(Sharecast News) - Ixico announced on Monday that it has secured a new £3.5m contract to provide imaging services for a global phase three clinical trial in Huntington's disease, marking a significant commercial win for the neuroscience-focused biomarker analytics group.
By Josh White
Date: Wednesday 15 Oct 2025
(Sharecast News) - Ixico announced two new agreements worth a combined £1.2m on Wednesday, including a contract to support the validation of a diagnostic blood test and an extension to an existing Alzheimer's disease clinical trial.
| Currency | UK Pounds |
| Share Price | 10.75p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 14.00 |
| 52 Week Low | 7.75 |
| Volume | 26,334 |
| Shares Issued | 92.67m |
| Market Cap | £9.96m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 13:15 | 2 @ 11.46p |
| 09:45 | 8,030 @ 10.50p |
| 09:43 | 18,302 @ 10.90p |
You are here: research